Medical Research News

RSS

Inhibiting PTP1B protein improves memory in Alzheimer’s disease models

Alzheimer's disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into the trillions.

5 Feb 2026

Ulcerative proctitis not linked to increased rectal cancer risk

People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population.

5 Feb 2026

Enhanced natural killer cells show promise for HIV remission

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).

5 Feb 2026

New report highlights a rare case of 5-fluorouracil-induced hyperammonemic encephalopathy

A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled "Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy."

5 Feb 2026

Liver-derived protein supports bone health in males

New research suggests the liver plays a previously unrecognized role in bone health, but only in males.

5 Feb 2026

Psychosocial factors strongly influence diet quality in rural adults

A large cross-sectional study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined how psychosocial and environmental factors relate to diet quality among 2,420 adults living in rural and micropolitan communities in New York and Texas.

5 Feb 2026

Reprogrammed neutrophils promote tumor growth

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumor ecosystem and contribute to its progression.

5 Feb 2026

Study calls for inclusive dementia research practices in Canada

A new Canadian study has found that people living with dementia (PLWD) are often excluded from research due to assumptions of incapacity and variations in institutional processes.

5 Feb 2026

Artificial lung keeps patient alive after lung removal

Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.

5 Feb 2026

Study reveals evidence of silent mpox exposure in healthy Nigerians

New evidence suggests that mpox may be circulating quietly among healthy Nigerians, with some infections occurring without the symptoms that typically trigger detection by health authorities.

5 Feb 2026

Influenza D virus and canine coronavirus pose human risks

Two emerging pathogens with animal origins - influenza D virus and canine coronavirus - have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans.

5 Feb 2026

EBV-linked killer T cells implicated in multiple sclerosis

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans.

5 Feb 2026

Gut microbial butyrate enhances mucosal vaccine antibody responses

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing how butyrate-a short-chain fatty acid produced by gut commensal bacteria-enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.

4 Feb 2026

Therapeutic potential of engineered extracellular vesicles in osteoarthritis

Announcing a new article publication for BIO Integration journal. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells and have emerged as promising therapeutic agents for osteoarthritis (OA).

4 Feb 2026

Too many antioxidants may negatively affect future offspring

Antioxidants have been marketed as miracle supplements, touted for preventing chronic diseases and cancers; treating COPD and dementia; and slowing aging.

4 Feb 2026

Carotid artery procedures do not improve cognitive performance

Improving blood flow to the brain by opening a narrowed neck artery may not improve patients' cognitive skills, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

4 Feb 2026

Study reveals what drives PFAS exposure in firefighters and how risks may be reduced

A large U.S. firefighter cohort study identified personal, occupational, and department-level predictors of serum PFAS concentrations, highlighting both modifiable exposures and persistent background sources. Some protective practices, blood or plasma donation, and drinking water sources were associated with differences in specific PFAS analytes, although causal relationships require further longitudinal study.

4 Feb 2026

Post-thrombectomy alteplase linked to better stroke outcomes

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary late-breaking science presented at the American Stroke Association's International Stroke Conference 2026.

4 Feb 2026

Breakthrough enables continuous laboratory growth of human norovirus

Researchers at Baylor College of Medicine report in Science Advances a breakthrough in human norovirus (HuNoV) research.

4 Feb 2026

DNA marker reveals pyrethroid resistance in malaria mosquitoes

A new study, jointly led by Liverpool School of Tropical Medicine and the Centre for Research in Infectious Diseases (CRID) in Cameroon, has detected a DNA marker in a gene encoding for a key enzyme, known as cytochrome P450, that helps mosquitoes to break down and survive exposure to pyrethroids, the main insecticides used for treating bed nets.

4 Feb 2026